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The in vitro activity of the aqueous extract of Phyllanthus muellerianus leaves against some selected 
organisms was investigated. The aqueous extract of P. muellerianus leaves was subjected to 
phytochemical screening. In addition, its antibacterial activity against clinical isolates, including 
Escherichia coli, Bacillus cereus, Salmonella typhi and Staphylococcus aureus was determined at 1.25, 
2.50, 5.00, 10.00, 12.50, 25.00 and 50.00 mg/ml body weight in albino rats. Phytochemical screening 
revealed amongst others the presence of cardenolides (0.33%), cardiac glycosides (0.51%), flavonoids 
(0.16%), saponins (1.21%), tannins (0.68%), phenolics (0.55%) and terpenoids (0.08%). Antibacterial 
study revealed that the aqueous extract of P. muellerianus leaves was bacteriostatic for about 15 hours 
on all the tested organisms except Proteus mirabilis which showed growth at all the concentrations used. 
Consequently, the data in the present study indicates that the aqueous extract of P.  muellerianus leaves 
possessed antibacterial properties, being most effective at 50.00 mg/kg body weight. 
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Medicinal plants form important component of 
the natural wealth of Nigeria [1] and constitute 
an effective source of both traditional and 
modern medicines. About 80% of the rural 
population depends on herbal medicine as 
primary health care [2]. Going by this, herbal 
medicine has been widely used and forms an 
integral part of primary health care in Nigeria, 
China, Argentina, Ethiopia and Papau New 
Guinea [3-7]. Herbal medicine is gaining 
popularity in developing countries [8]. Herbal 
treatments involve mainly the use of plant 
extracts and other plant products [9-10] which 
contain bioactive substances. Phyllanthus 
muellerianus is one of these herbs that are 
locally used frequently for the treatment of 
different ailments in Nigeria. 
 
Phyllanthus muellerianus otherwise known as 
“Eegun eja” (Yoruba-Western Nigeria) was 
formally classified as one of the flowering trees 
of spurge family (Euphorbiaceae). However, a 
recent revision of classification has categorised 
Phyllanthus under the family Phyllanthaceae 
[11]. P. muellerianus is widely spread in tropical 
Africa [12]. Apart from Nigeria, it is also found in 
other countries like China, Cuba, Philippines, 
central and southern India [13]. Although 
common in the tropics, the Phyllanthus specie of 
interest is generally often scattered in 
distribution [14]. 
  
The ethnobotanical uses of the plant include the 
treatment of diarrhoea, toothache, sexual 
dysfunction, chest pain, conjunctivitis, fever, 
paralysis, sore throat, urethritis, gonorrhoea and 
wound [15], many out of which are caused by 
bacteria. In view of the fact that many bacteria 
are now showing resistance against many 
bacteria, alternatives to the existing antibacterial 
drugs have to be provided as a matter of 
urgency.  
 
This    research    is    therefore    designed   to: 
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a) determine the phytochemical constituents of 
P. muellerianus leaves; 
b) evaluate the in vitro antibacterial activity of 
the aqueous extract of P. muellerianus    leaves 
against some selected diarrhoea causing 
organisms. 
   




2.1.1 The Plant: Collection and Identification 
 
Phyllanthus muellerianus was collected within 
the premises of Government Day Secondary 
School, Oke Adinni, Ilorin, Kwara State, Nigeria. 
It was authenticated at Forestry Research 
Institute of Nigeria (FRIN), Ibadan, where a 
voucher specimen (FHI 108364) was deposited. 
 
2.1.2 Bacteria isolates 
 
Bacteria Isolates (Escherichia coli, 
Staphylococcus aureus, Salmonella typhi, 
Shigella flexneri, Bacillus cereus, Proteus 
mirabilis, Streptococcus pyogenes and 
Klebsiella pneumonia) were obtained from the 
Department of Pathology, University of Ilorin 
Teaching Hospital, Ilorin, Kwara State, Nigeria. 
 
2.1.3. Reagents and Chemicals 
 
Nutrient agar, nutrient broth, Muller-Hinton agar 
and agar-agar were all products of Biotec 
Laboratories Ltd., United Kingdom. All other 
reagents used were of analytical grade and 




2.2.1 Preparation of aqueous extract of 
Phyllanthus muellerianus leaves 
 
The preparation was carried out following the 
method described by Adedapo et al [13]. Leaves 
of P. muellerianus were harvested (as always 
freshly harvested by the traditional medicine 
practitioners) after which 500 g was blended 
and 2.75 litres of distilled water added, allowed 
to stand for 48 hours but shaken intermittently 
with electric stirrer. The suspension was then 
filtered using Whatman No. 1 filter paper and 
the filterate was lyophilized (with 1.5 litre ice 
capacity model of FS400-05 Freeze Dryer, 
Micromodulyo; USA). The lyophilized sample 
was reconstituted in distilled water to prepare 
different doses (12.50, 25.00 and 50.00 mg/kg 
body weight) that were administered to different 
groups of animals. The doses were informed 
from the bacteriostatic activity displayed by the 
extract during the antibacterial studies.  
 
2.2.2 Quantitave estimates of Phytochemicals 
in Phyllanthus muellerianus leaves 
 
Cardiac glycosides and Terpenoids: The 
procedure described by Sofowora [16] was 
used.  
Flavonoids: The procedure described by Allen 
[17] was used.  
Cardenolides: The procedure described by 
Edeoga et al [18] was used.  
Phenolics: The procedure described by 
Harborne [19] was used.  
Saponins: The spectrophotometric method 
described by Brunner [20] was used for the 
quantitative determination of saponins.  
Tannins: The procedure described by Swain 
[21] was used.  
 
2.2.3 Preparation of Mueller-Hinton agar, 
nutrient broth and nutrient agar 
 
The method of Fawole and Oso [22] was used 
to prepare agars and broth. 
 
2.2.4 Standardisation of bacterial inoculation 
 
Standardisation of bacterial inoculum was 
carried out using the procedure described by 
Bauer et al [23] and Barry and Thornsberry [24]. 
 
2.2.4 Determination of minimum inhibitory 
concentration (MIC) and minimum 
bactericidal concentration (MBC) 
 
The aqueous extract of P. muellerianus leaves 
at the concentrations of 1.25, 2.50, 5.00, 10.00, 
12.50, 25.00 and 50.00 mg/ml were prepared 
into different test tubes containing broth agar 
and 0.1 ml of standardised inoculum 
(Escherichia coli) was added to the tubes. The 
procedure was repeated for the remaining 
bacteria (Staphylococcus aureus, Salmonella 
typhi, Bacillus cereus, Shigella flexneri, Proteus 
mirabilis, Klebsiella pneumonia and 
Streptococcus pyogene). All the tubes were 
incubated at 37
0
C for 24 hours. Two control 
tubes were maintained for the test. These 
included the tube containing extract and broth 
without inoculum (negative control or aqueous 
extract control) and the tube containing the 
broth, distilled water and the inoculum (positive 
control or organism control). The lowest 
concentration (highest dilution) of the extract 
that produced no visible bacterial growth (no 
turbidity) when compared with the control tube 
was regarded as the minimum inhibitory 
concentration (MIC).  
 
However, the minimum bactericidal 
concentration (MBC) was determined by sub-
culturing the dilution that gives the MIC (the test 
dilution) on to the fresh nutrient agar and 
incubated further for 24 hours. The highest 
dilution that yielded no single bacteria colony on 
a solid medium was taken as MBC [25]. 
 
2.3 Statistical analysis 
 
Data were expressed as means ± S.D of five 
determinations except otherwise stated. The 
statistical tools used were one-way analysis of 
variance (ANOVA) and Duncan Multiple Range 
Test. Differences were considered statistically 
significant at P < 0.05 [26]. 
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Of all the phytochemicals identified in the 
aqueous extract, saponins constituted the 
highest percentage with 34.38 while terpenoids 
was found to be the least (2.27%) (Table1). 
 
The aqueous extract of P. muellerianus leaves 
produced concentration dependent effect on the 
diameter of zones of inhibition of the tested 
organisms.  For instance, whereas the least 
dose of the extract (1.25 mg/ml) produced 
minimal zone of inhibition ranging from 14 – 17 
mm on all the tested organisms, the highest 
dose (50 mg/ml) produced diameter of zone of 
inhibition within the range of 24 - 36 mm. At the 
highest dose of the extract, B. cereus had the 
least diameter of zone of inhibition whereas the 
extract produced the highest diameter of zone of 
inhibition on E. coli (Table 2). 
 
The growth of Bacillus cereus, Klebsiella 
pneumonia and Staphylococcus aureus was 
inhibited at all the doses (1.25 – 50 mg/ml) of 
the extract used in the study.  Furthermore, the 
growth of E. coli and Shigella flexneri was 
similar as they were both inhibited within the 
concentration range of 10 – 50.00 mg/ml 
whereas Streptococcus pyrogenes and 
Salmonella typhi were inhibited at 2.50 and 5.00 
mg/ml, respectively.  However, the extract did 
not inhibit the growth of Proteus mirabilis at all 
the doses investigated in the present study 
(Table 3).  At the concentrations tested, the 
aqueous extract of P. muellerianus leaves 
prevented growth of all the bacteria tested for 15 
hours. By 20
th
 hour, B. cereus and Shigella 
flexneri had stated to grow. This pattern was 
extended to all other organisms by 24
th 
hour 
experimental period (Table 4). 
 
Table 1. Phytochemical constituents of aqueous 
extract of Phyllanthus muellerianus leaves. 
Phytochemicals Concentration (%) 
 
Alkaloids Not detected 
Anthraquinones Not detected 
Cardenolides 0.33 ± 0.02 
Cardiac 
Glycosides 
0.51 ± 0.00 
Flavonoids 0.16 ± 0.01 
Phenolics 0.55 ± 0.02 
Phlobatannins Not detected 
Saponins 1.21 ± 0.03 
Steroids Not detected 
Tannins 0.68  ± 0.03 
Terpenoids 0.08  ± 0.00 
 
Values are mean of three determinations ± S.D.
 
 
Table 2: Diameter of zones of inhibition by aqueous extract of Phyllanthus muellerianus leaves on 
selected bacteria. 
   
Diameter* of Zones of inhibition on the test organisms (mm) 
Extract 
(mg/ml) 










































   2.50 14.83+0.17a 18.33+0.33d 18.00+ 0.00d 18.00+ 0.00d 16.00+0.00b 16.67+ 0.17c 17.00+ 0.00d 18.00+ 0.00d 
   5.00 16.00+0.58a 20.67+0.33d 20.00+0.58cd 19.17+0.17c 18.00+0.00b 18.00+ 0.00b 20.00+0.00cd 20.00+0.00cd 
  10.00 20.00+0.58a 21.50+0.29b 24.00+0.00d 21.00+0.58ab 23.00+0.58c 21.00+0.00ab 23.00+0.00c 25.00+0.00cd 
  12.50 22.00+0.58a 23.00+0.33b 26.00+0.00e 22.00+0.00a 25.00+0.00d 24.00+0.00bc 24.33+0.33cd 26.67+0.33e 
25.00 23.33+0.89a 24.00+0.00a 33.67+0.17d 23.17+0.17a 26.83+0.44b 26.00+0.00b 26.00+0.00b 30.00+0.00c 
50.00 24.33+0.89a 25.33+0.33a 36.00+0.00e 30.00+0.58b 34.00+0.00d 33.33+0.17cd 33.00+0.00cd 32.33+0.33c 
Values are mean of three determinations ± S.D. 
* indicates the extent of inhibition of growth 
G +ve indicates Gram positive; G -ve indicates Gram negative 
 
 
Table 3: Minimum inhibitory concentration of aqueous extract of Phyllanthus 
muellerianus leaves on selected bacteria 
Microorganisms                        Extract concentration (mg/ml) 
                                           1.25               2.50           5.00            10.00            12.50             25.00          50.00    
Bacillus cereus                   -
a
                    -                -                   -                   -                      -                 - 
Salmonella typhi                 +
b
                  +                -                   -                   -                      -                 -    
Escherichia coli                   +                   +               +                   -                   -                      -                 - 
Klebsiella pneumonia          -                    -                -                   -                    -                      -                 -     
Proteus mirabilis                 +                   +                +                  +                  +                     +                 + 
Shigella flexneri                  +                   +                +                  -                    -                     -                  - 
Staphylococcus aureus       -                    -                 -                  -                    -                     -                  - 
Streptococcus pyogenes    +                    -                 -                  -                    -                     -                  - 
-
a
 Indicates no growth;  +
b
 Indicates growth 
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Table 4. Bacteriostatic activity of aqueous extract of Phyllanthus muellerianus leaves on selected bacteria. 
Bacteria 
MIC of the extract 
 
                    Period of observation (hour) 
 
5 10              15               20              24 
Bacillus cereus 1.25 -
a
  -                   -               +
b
               + 
Salmonella typhi 5.00 -  -                   -                -                + 
Escherichia coli 10.00 -  -                   -                -                + 
Klebsiella pneumonia 1.25 -  -                   -                -                + 
Shigella flexneri 10.00 -  -                   -                +               + 
Staphyloccocus aureus 1.25 -  -                   -                -                + 
Streptoccocus pyrogenes 2.50 -  -                   -                -                + 
-
a
 Indicates no growth; +
b






The bioactives found in the medicinal plants 
have potentials to prevent or cause adverse 
effects [27]. For example, tannins have been 
reported to possess antibacterial properties 
which act by different mechanisms, including 
enzyme inhibition, reduction in oxidative 
phosphorylation and iron deprivation amongst 
others [28]. Similarly, saponins have also been 
implicated to exhibit antibacterial activities 
[29].The present study showed that aqueous 
extract of P. muellerianus leaves contained 
phytochemicals, which on application inhibited 
the growth of both gramme positive and 
gramme negative bacteria that resulted in the 
observed diameter of zones of inhibition of the 
test bacteria. The concentration dependent 
diameter of zones of inhibition observed on 
some of these bacteria suggested antibacterial 
activity of the extract. However, the doses of 
extract used in this study exhibited bacteriostatic 
activity for only 15 hours. Therefore, one or 
more of these phytoconstituents might be 
responsible singly or in combination for the 
observed effect of the extract. 
  
Several workers had employed the principles of 
minimum inhibitory concentration (MIC) values 
as a measure of effectiveness of antibacterial 
agents [29-31]. Therefore, the pattern of MIC 
and the bacteriostatic results on the test 
organisms indicated antibacterial activity of the 
extract. The least values obtained on B. cereus, 
K. pneumonia, and S. aureus as well as on the 
other organisms suggested that the plant extract 
is less potent as an antibacterial agent on these 
organisms. Furthermore, it is worthy of note that 
the extract is not effective on P. mirabilis since it 
did not inhibit the growth of this organism. 
  
Diarrhoea-causing organisms constitute the 
major causes of mortality in several countries of 
the world [32], some of which are gram-negative 
bacteria. Gram-negative bacteria are frequently 
reported to have developed multi-drug  
resistance to many of the well-known antibiotics 
currently available in the market of which 
Escherichia coli is the most prominent [33-35]. 
The in vitro antibacterial activity of the extract on 
the diarrhoea-causing bacteria such as 
Escherichia coli, Shigella flexneri, Salmonella 
typhi and Staphylococcus aureus might justify 
the folkloric use of the plant as an antidiarrhoea 
agent. Therefore, the effectiveness of the 
extract against some diarrhoea-causing 
organism may account for the acclaimed use of 




The effects of aqueous extract of P. 
muellerianus leaves on bacterial isolates 
reavealed that it was bacteriostatic on 
Escherichia coli, Shigella flexneri, Salmonella 
typhi, Staphylococcus aureus which are 
diarrhoea-causing bacteria and other tested 
bacteria such as Bacillus cereus, Klebsiella 
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